Ascendis Health Limited

Equities

ASC

ZAE000185005

Pharmaceuticals

End-of-day quote Johannesburg S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
0.8 ZAR 0.00% Intraday chart for Ascendis Health Limited 0.00% +2.56%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Ascendis Health Seeks Acquisitions CI
Ascendis Health Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI
Ascendis Health Limited Provides Earnings Guidance for the Six Months Ended 31 December 2023 CI
Ascendis Health Limited Announces Board Changes CI
Ascendis Health Limited Announces Lawrence Mulaudzi Not Available for Re-Election as Director CI
Ascendis Health Limited Reports Earnings Results for the Full Year Ended June 30, 2023 CI
Ascendis Health Limited Appoints Joseph Fine as Company Secretary CI
Ascendis Health Flags Drop in FY23 EPS MT
Ascendis Health Limited Provides Earnings Guidance for the Year Ended 30 June 2023 CI
Ascendis Health Advances Cost-cutting Program With New Auditor MT
Ascendis Health Books Lower Fiscal H1 Attributable Profit MT
Ascendis Health Terminates PricewaterhouseCoopers as Auditor MT
South African Stocks End Tumultuous Week in the Red MT
Ascendis Health Flags Lower EPS in Fiscal H1 MT
Ascendis Health Limited Appoints Bharti Harie as Chairman of the Board CI
Ascendis Health Limited Reports Earnings Results for the Full Year Ended June 30, 2022 CI
Ascendis Health Limited Reports Earnings Results for the Full Year Ended June 30, 2022 CI
Transcript : Ascendis Health Limited, 2022 Earnings Call, Sep 28, 2022
Ascendis Health Limited Auditor Raises 'Going Concern' Doubt CI
Ascendis Health Limited Announces Resignation of Richard Dawes an Independent Non-Executive Director CI
Pharma-Q Holdings Ltd. and Imperial Logistics Limited cancelled the acquisition of Medicine Developers International/Pharmachem Pharmaceuticals/Alliance Pharma/Ascendis Pharma from Ascendis Health Limited. CI
Ascendis Health Limited Announces Board Changes CI
Ascendis Health Limited Announces Resignation of Gary Shayne as A Non-Executive Director CI
Ascendis Health Limited Appoints Riyas Fadal as Chief Operating Officer CI
Ascendis Health Seeks Acquisitions CI
Chart Ascendis Health Limited
More charts
Ascendis Health Limited specializes in developing, manufacturing and marketing care and health products. Net sales break down by family of products as follows: - pharmaceutical products (61.3%): primarily prescription drugs. The group also provides medical devices used in the radiology and surgery fields; - consumer products (31%): OTC medicines, vitamins and minerals, homeopathic products, ayurvedic products, sports nutrition products, functional foods, etc.; - care products for plants and animals (7.7%). Net sales are distributed geographically as follows: South Africa (71.3%), Cyprus (16%) and Romania (12.7%).
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ASC Stock
  4. News Ascendis Health Limited
  5. Ascendis Health Books Lower Fiscal H1 Attributable Profit